文献速递姑息放疗与转移瘤

短程姑息性放射治疗可实现优异的出血控制:一项单中心回顾性研究

Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study.
PubMed 文献 · Clin Transl Radiat Oncol · 2018-11-22

该单中心回顾性研究分析112例因肿瘤出血接受急诊姑息放疗的患者,比较不同分割方案的止血效果。总体初次止血率89%,再出血率25%,1年总生存率24%;长程方案(>5次)未降低再出血,但治疗中断更多。作者认为短程方案(<5次)在保证止血效果的同时可减轻治疗负担。

要点

  • 总体初次止血率89%,再出血率25%,1年总生存率24%。
  • 长程方案(>5次)未降低再出血(p=0.65),但治疗中断更多(p=0.02)。
  • 作者认为短程方案(<5次)在此姑息场景中更可取。

核心结论

  • 无论处方如何,姑息性放疗对初次出血控制均高度有效,长程与短程方案在急诊止血效果和持久性上相当。
  • 长程放疗方案(>5次)伴随治疗中断和住院天数增加。
  • 作者认为,在保证症状缓解的同时为减少治疗负担,短程止血方案(<5次)在此姑息场景中更可取。

研究设计与样本

  • 单中心回顾性研究,分析112例连续接受放疗以急诊姑息止血的肿瘤出血患者。
  • 研究终点包括初次出血控制、初次控制后再出血率、治疗中断率、总生存及治疗30天内死亡。

主要发现

  • 最常用分割方案为20 Gy分5次、30 Gy分10次和8 Gy单次。
  • 总体初次止血率为89%。
  • 按部位初次止血率分别为:胃肠道89%(31/35)、泌尿生殖道80%(16/20)、头颈部88%(14/16)、胸部93%(13/14)、四肢100%(9/9)、妇科100%(6/6)。
  • 初次止血控制后总体再出血率为25%。
  • 女性患者再出血风险显著降低(HR 0.18 [0.04-0.79],p=0.02)。

关键数值与推荐

  • 最常用分割方案:20 Gy分5次、30 Gy分10次、8 Gy单次。
  • 总体初次止血率89%,再出血率25%,1年总生存率24%。
  • 长程方案(>5次)与再出血无关(p=0.65),与治疗中断相关(p=0.02)。

临床怎么用

  • 作者认为,在此姑息止血场景中,短程方案(<5次)更可取,可在实现症状缓解的同时减少治疗负担。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare and evaluate the utility of varying hemostatic radiotherapy prescriptions for emergent palliation of bleeding tumors. MATERIALS AND METHODS: This retrospective study analyzed 112 consecutive patients treated with radiotherapy for emergent palliation of bleeding tumors at an academic institution. Study endpoints included: primary bleeding control; re-bleeding rate after initial control; treatment interruption rate; overall survival; and death within 30 days of treatment. RESULTS: The most commonly prescribed fractionations were: 20 Gy in 5 fractions, 30 Gy in 10 fractions, and 8 Gy in a single fraction. The overall primary bleeding control rate was 89%. By location, primary bleeding control rates were 89% (31/35), 80% (16/20), 88% (14/16), 93% (13/14), 100% (9/9), and 100% (6/6) for gastrointestinal, genitourinary, head and neck, thoracic, extremity, and gynecologic sites, respectively. The overall re-bleeding rate following initial bleeding control was 25%. Female patients had a significantly reduced risk of bleeding recurrence (HR 0.18 [0.04-0.79], p = 0.02). Longer fractionation regimens (>5 fractions) were not associated with a reduced incidence of re-bleeding (p = 0.65), but were associated with more treatment interruptions (p = 0.02). The 1-year overall survival rate in this population was 24%, with mortality greater in patients with poor performance status (HR 2.99 [1.36-6.58], p = 0.007). CONCLUSIONS: Regardless of prescription, palliative radiotherapy is highly effective for primary bleeding control, with both long and short regimens demonstrating equal hemostatic effect and durability in the emergent setting. Longer radiotherapy regimens (>5 fractions), however, are accompanied by increased treatment interruptions and hospital days. Therefore, shorter hemostatic regimens (<5 fractions) are preferable in this palliative setting, with respect to minimizing treatment burden for patients while achieving symptomatic relief.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Sapienza LG, Ning MS, Jhingran A, et al. Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study. Clin Transl Radiat Oncol. 2018. PMID: 30555940. doi:10.1016/j.ctro.2018.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。